Rudi-Busse-Young Investigator Award für experimentelle Herz-Kreislaufforschung
Vorsitz: M. Hecker (Heidelberg), T. Wieland (Mannheim), K. C. Wollert (Hannover)
| (V907) | Histone deacetylase 4 interaction with histone methyltransferase SUV39H1 is disrupted in response to prohypertrophic stimuli and controls ANP gene reactivation in heart failure |
| M. Wagner, M. Hohl, S. A. Müller, M. Tauchnitz, A. M. Zimmer, L. H. Lehmann, M. Böhm, J. Backs, C. Maack (Homburg/Saar, Heidelberg) | |
| (V908) | MiRNA-146a, a downstream effector of 16K prolactin, is a therapeutic target and a specific biomarker for peripartum cardiomyopathy |
| M. Ricke-Hoch, J. Halkein, S. Tabruyn, A. Haghikia, K. Castermans, L. Malvaux, V. Lambert, K. Sliwa-Hähnle, A. Noel, J. Martial, M. Scherr, I. Struman, D. Hilfiker-Kleiner (Hannover; Liege, BE; Cape Town, ZA) | |
| (V909) | Reverse mode of the mitochondrial transhydrogenase during elevated cardiac afterload triggers NADPH oxidation and reactive oxygen species-dependent induction of apoptosis, necrosis and fibrosis |
| A. Nickel, J. R. Löffler, J.-C. Reil, A. Hardenberg, M. Kohlhaas, J. Bonnekoh, M. Hohl, A. Kazakov, B. Pasieka, I. Bogeski, R. Kappl, M. Hoth, M. Böhm, C. Maack (Homburg/Saar) | |
| (V910) | Histone Deacetylase 4 (HDAC4) is a key regulator in the transition of physiological to pathological cardiac remodeling |
| L. H. Lehmann, M. Kreußer, Z. H. Jebessa, A. Horsch, N. Gretz, H.-J. Gröne, H. A. Katus, J. Backs (Heidelberg, Mannheim) |